SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.

Reasons you should not miss this incredible event includes:

• Discuss developments in tools, techniques and procedures used in identification and control of contaminants
• Evaluate the handling of traditional drug and biologics & sterile product manufacturing
• Hear about design, construction and validation of sterile facilities and equipment
• Engage with those currently working on producing the rapid microbial methods

Key Speakers include:

• Oliver Chancel, Microbiologist, Sanofi-Aventis
• Kim Bowers, Senior Scientist, Pfizer
• Praful Bhusari, Associate Scientist, MedImmune
• John Duguid, Principle Analytical Scientist, Genzyme
• Scott Smith, Microbiology Team Leader, Sanofi-Aventis
• Anne Warford, Associate Director, MedImmune
• Amy McDaniel, Director, QC Microbiology, Pfizer
• Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
• Brendan Gilmore, Research Scientist, Queens University Belfast
• Andrew Bartko, Senior Scientist, Battelle Research Institute
• Hilary Chan, Quality Scientist IV, Pfizer
• Mark Thompson, Consultant, EPIC Consultancy & Training
• Daniel Kockelkorn, Head of PKau Laboratory, Roche
• Emiliano Toso, Principle Scientist, Merck
• Gunther Meike, System Development Specialist, Charles River Laboratories

Book by 28th September and receive a £300 discount